Indeed, the rhythmic trafficking of DCs to the melanoma tumor draining lymph node governs a circadian response of tumor antigen-specific CD8+ T-cells that is dependent on the circadian expression of the co-stimulatory molecule CD80 [175]. The gene discussed is CD80; the disease is melanoma.